Demographics And Clinical Characteristics Of Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Awwb In Real-World Oncology Clinics

JOURNAL OF CLINICAL ONCOLOGY(2021)

引用 1|浏览3
暂无评分
摘要
90Background: Bevacizumab-awwb is a biosimilar to bevacizumab approved by the FDA based on evidence obtained in a phase 3 study in non-squamous non-small cell lung cancer. The present real-world ev...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要